|
|
 |
|
Viewing report
|
|
|
|
Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools
John Wiley and Sons Ltd, July 2010, Pages: 432
Explores current and emerging applications of microbes as cancer-fighting agents
Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes millions of lives every year around the world. In recent years, researchers have been working on a new strategy: developing microbes and microbial products that specifically attack cancer cells.
This book breaks new ground in emerging cancer treatment modalities by presenting recent advances in the use of micro-organisms and viruses as well as their products in cancer therapy. Seventeen chapters review the application of live micro-organisms, high and low molecular weight products derived from micro-organisms, and microbial products fused to cancer-targeting molecules. In addition, the book highlights the benefits of a multi-target approach to destroy cancer cells. Readers will not only discover the results and significance of basic and clinical research, but also encouraging results from clinical trials.
Emerging Cancer Therapy is divided into three sections:
- Section 1: Live/Attenuated Bacteria and Viruses as Anticancer Agents
- Section 2: Bacterial Products as Anticancer Agents
- Section 3: Patents on Bacteria/Bacterial Products as Anticancer Agents
With chapters written by leading pioneers in microbial, biotech, and cancer research, Emerging Cancer Therapy is recommended for biotechnologists, microbiologists, clinical oncologists, medicinal chemists, and biochemists. Readers will not only learn the tremendous potential of microbial and biotechnological approaches to cancer therapy, but also discover new directions of research for effective drug discovery and development.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Drug Delivery in Cancer - Technologies, Markets and Companies
Personalized Medicine - Scientific and Commercial Aspects
Cancer Drug Resistance
Royalty Rates for Pharmaceuticals & Biotechnology, 7th Edition
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Cancer Bundle
Apoptosis 2009: Opportunities in Cancer and Other Diseases
Cancer Drugs with Apoptotic Targets in Development
Transdermal Drug Delivery - Technologies, Markets, and Companies
|
|
|
|
